Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-076-8 | CAS number: 7785-23-1
Endpoint summary
Administrative data
Description of key information
A tentative assessment of the repeated dose toxicity of AgBr is presented. The hazard assessment for this and other inorganic silver substances is based on the silver ion or elemental silver. The other ions or moieties contained in the different substances (e.g. Cl, Br, I, nitrate...) are not considered to contribute to the systemic toxicity. Thus, grouping these substances is justified.
Because limited relevant/reliable toxicological data is available, some results of the assessment of repeated dose toxicity of silver compounds have to be seen as tentative and will be revised in the future. The registrant (organised in the precious metals consortium) is aware of relevant on-going long-term toxicological studies, such as on nano-silver and silver acetate. It is expected that this data becomes available during 2013, after which the hazard assessment will be revised.
Silver bromide is considered a poorly soluble substance of low to negligible bioavailability. Thus, it is grouped together with Ag, Ag2O, AgCl and AgI into the group of insoluble/poorly soluble silver substances (see also introduction to chapter 5 in the CSR).
Further details are presented in the report “Derivation of DNELs for poorly soluble and soluble silver compounds”, which is attached to the endpoint summary on toxicological information in the technical dossier and to the CSR.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- NOAEL
- 30 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Key study. NOAEL expressed as mg Ag/kgbw/day!
Justification for selection of repeated dose toxicity inhalation - systemic effects endpoint:
Waiving. The SCOEL occupational exposure limit is adopted as the DNEL for systemic effects via inhalation for workers.
Justification for selection of repeated dose toxicity inhalation - local effects endpoint:
Waiving.
Justification for selection of repeated dose toxicity dermal - systemic effects endpoint:
Waiving.
Justification for selection of repeated dose toxicity dermal - local effects endpoint:
Waiving.
Repeated dose toxicity: via oral route - systemic effects (target organ) digestive: liver
Justification for classification or non-classification
The current knowledge about toxicological effects of silver substances in general and silver chloride in particular leads to the conclusion that hazard classification is not required for any CLP classification criterion related to repeated exposure.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
